News
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Regarding injection site rotation, alternate between different areas like the abdomen, thigh, or upper arm to prevent ...
Danish pharmaceutical company Novo Nordisk has officially launched its once-weekly injectable weight management drug, Wegovy® (semaglutide 2.4mg), in Singapore. The treatment received regulatory ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
15h
NDTV Profit on MSNCipla To Take On Eli Lilly, Novo Nordisk With Entry Into India's Weigh-Loss Drug SectorCipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.
17h
Daily Star on MSN'I’ve gone from 23 stone to 11 stone – and no, it wasn’t down to fat jabs'EXCLUSIVE: Sam Johnston tried a host of other diets, would lose a few pounds, but put it straight back on - so when the doctor told him he was unhealthily overweight, he decided to take action ...
A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...
Earlier in the week, Mr. Trump said he would also impose a 50-per-cent tariff on copper and 200 per cent on pharmaceuticals – ...
New Delhi: Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results